Pms74 - The Role of Monitoring Compliance to Guidelines in Preventing the Risk of Second Fracture and Death in Patients With Osteoporosis: A Retrospective Administrative Database Analysis.

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1788
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Is Withholding Osteoporosis Medication After Fracture Sometimes Rational? A Comparison of the Risk for Second Fracture Versus Death

Journal of the American Medical Directors Association
MedicineHealth PolicyGerontologyGeriatricsNursing
2010English

Evaluation of Current Practice: Compliance With Osteoporosis Clinical Guidelines in an Outpatient Fracture Clinic

Australian Health Review
Health Policy
2008English

A Comparison of Fosaprepitant and Ondansetron for Preventing Postoperative Nausea and Vomiting in Moderate to High Risk Patients: A Retrospective Database Analysis

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2017English

GP266 a Retrospective Audit of the Incidence of Hypoglycaemia in at Risk Neonates and Compliance With Local Guidelines

2019English

Interrelation of Risk Factors and Occurrence of a Possible Fracture in Patients With Osteoporosis

Balneo Research Journal
2018English

Pms13 - Real-World Treatment of Patients With Osteoporosis in Germany: Prevalence and Incidence of Patients With Osteoporosis at Increased Fracture Risk

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pms43 - An Economic Value Framework to Assess the Cost Effectiveness of Fracture Prevention Treatments in Patients With Osteoporosis at Imminent Risk of Fracture

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Systematic Review of Compliance to Bisphosphonates in Patients With Osteoporosis in RCT and Real Practice

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Prescriber Compliance With Liver Monitoring Guidelines for Pazopanib in the Postapproval Setting

Journal of Patient Safety
EnvironmentalPublic HealthLeadershipManagementOccupational Health
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy